02Jun/13

Highlights from ASCO: Bayer's Nexavar; Novartis' Afinitor; and Amgen's … – The Pharma Letter

Highlights from ASCO: Bayer’s Nexavar; Novartis’ Afinitor; and Amgen’s
The Pharma Letter
Also at ASCO yesterday, Swiss drug major Novartis (NOVN: VX) presented results from a pivotal Phase III trial of a treatment regimen including Afinitor (everolimus) tablets in women with human epidermal growth factor receptor-2 positive (HER2 positive)

and more »

02Jun/13

Novartis pivotal Phase III trial shows Afinitor significantly delays tumor … – MarketWatch (press release)

Novartis pivotal Phase III trial shows Afinitor significantly delays tumor
MarketWatch (press release)
EAST HANOVER, N.J., June 2, 2013 /PRNewswire via COMTEX/ — Novartis today presented results from a pivotal Phase III trial of a treatment regimen including Afinitor� (everolimus) tablets in women with human epidermal growth factor receptor-2 positive

and more »

02Jun/13

Delhi acid attack victim dies in Mumbai – Times of India


Daily News & Analysis

Delhi acid attack victim dies in Mumbai
Times of India
She was on a ventilator for the past two weeks as her right lung had collapsed and the left one was only partly functional. According to doctors attending to Rathi, her survival chances were as slim as five percent, given the extent of internal
Mumbai acid attack victim’s family meets RR Patil, demand CBI probe into incidentDaily News & Analysis
Maharashtra CM announces Rs 2 lakh ex-gratia to kin of acid attack victimZee News
Acid attack victim diesThe Asian Age

all 30 news articles »